Screener
Assembly Biosciences ASMB Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development | 14,900 | 14,851 |
| General and administrative | 4,683 | 4,509 |
| Total operating expenses | 19,583 | 19,360 |
| Loss from operations | (11,370) | (9,941) |
| Other income | ||
| Interest and other income, net | 2,291 | 1,123 |
| Total other income | 2,291 | 1,123 |
| Net loss | $(9,079) | $(8,818) |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's operating income?
- Assembly Biosciences (ASMB) reported operating income of -$11.37M in Q1 2026.
- How has Assembly Biosciences's operating income changed year-over-year?
- Assembly Biosciences's operating income decreased by 14.4% year-over-year, from -$9.94M to -$11.37M.
- What is the long-term trend for Assembly Biosciences's operating income?
- Over 3 years (2021 to 2024), Assembly Biosciences's operating income has grown at a -30.0% compound annual growth rate (CAGR), from -$132.69M to -$45.42M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Assembly Biosciences's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude